Share-based compensation - Options (Details) - $ / shares |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
Jun. 01, 2023 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
| Number of options over ordinary shares granted (in shares) | 7,082,892 | 5,996,581 | 59,070,294 | 30,608,533 | |
| Weighted average fair value of ordinary shares options (in dollars per share) | $ 0.12 | $ 0.21 | $ 0.12 | $ 0.37 | |
| Number of additional options with a nominal exercise price granted | 465,960 | 1,866,216 | 26,480,652 | 22,916,376 | |
| Weighted average fair value of options with a nominal exercise price | $ 0.15 | $ 0.28 | $ 0.27 | $ 0.53 | |
| Replacement Awards Granted To TCR2 Grantholders | |||||
| Number of options over ordinary shares granted (in shares) | 29,639,418 | ||||
| Number of additional options with a nominal exercise price granted | 5,501,196 | ||||
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. No definition available.
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted with nominal exercise price during the period. No definition available.
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|